Guidelines for medical management of hyperglycaemia in type 2 diabetes and duality of interest

Diabetologia

Volumn 52, Issue 3, 2009, Pages 550-551

  Eizirik, D L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; DRUG MARKETING; HYPERGLYCEMIA; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ALGORITHMS; CONFLICT (PSYCHOLOGY); CONSENSUS; DIABETES MELLITUS, TYPE 2; FINANCING, ORGANIZED; HUMANS; HYPERGLYCEMIA; PRACTICE GUIDELINES AS TOPIC;

EID: 59449101425     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-008-1225-3     Document Type: Letter

References (6)

1. Nathan DM, Buse JB, Davidson MB et al (2008) Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia doi: 10.1007/s00125-008-1157-y
2. PA Komesaroff MA Bach A Danoff 2004 The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interest, October 2003 Endocrinology 145 3032 3041
3. DF Thomson 1993 Understanding financial conflicts of interest N Engl J Med 329 573 576
4. JE Bekelman Y Li CP Gross 2003 Scope and impact of financial conflicts of interest in biomedical research: a systematic review JAMA 289 454 465
5. PA Komesaroff 2005 Ethical issues in the relationships with industry: An ongoing challenge. New guidelines open for public comment J Paediatr Child Health 41 558 560
6. EAM Gale 2003 Between two cultures: the expert clinician and the pharmaceutical industry Clin Med 3 538 541